ROSETREES ENTERPRISE FELLOWSHIP AWARD We are delighted to announce that Dr Christopher Chapman of Imperial College has been awarded a Rosetrees Enterprise Fellowship.  The £180,000 award will fund three years of development of an implantable device to deliver precision chemotherapeutic release. The aim is to significantly improve the efficacy of treatment for hard-to-treat cancers, such…

Read More